tiprankstipranks
Trending News
More News >
Christina Lake Cannabis Corp (TSE:CLC)
:CLC

Christina Lake Cannabis (CLC) AI Stock Analysis

Compare
12 Followers

Top Page

TSE:CLC

Christina Lake Cannabis

(OTC:CLC)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 4o)
Rating:45Neutral
Price Target:
C$0.04
▼(-2.50% Downside)
The overall stock score of 45 reflects significant challenges in financial performance, particularly in revenue growth and profitability. Technical analysis indicates a bearish trend, and valuation metrics are unattractive with a negative P/E ratio and no dividend yield. These factors collectively contribute to a lower stock score.
Positive Factors
Improved Leverage Management
Improved leverage management suggests better financial discipline, enhancing long-term stability and reducing financial risk.
Cash Flow Strength
Strong cash flow relative to earnings indicates effective cash generation, supporting operational needs and potential growth investments.
Stable Capital Structure
A stable capital structure with a reasonable proportion of equity financing provides financial resilience and flexibility for future growth.
Negative Factors
Declining Revenue Growth
Negative revenue growth indicates challenges in market penetration and sales momentum, potentially impacting long-term business viability.
Profitability Concerns
Significant drop in net profit margin reflects profitability challenges, potentially affecting reinvestment capacity and shareholder returns.
Declining Margins
Decreased margins suggest cost management issues or pricing pressures, which can erode competitive advantage and financial performance.

Christina Lake Cannabis (CLC) vs. iShares MSCI Canada ETF (EWC)

Christina Lake Cannabis Business Overview & Revenue Model

Company DescriptionChristina Lake Cannabis Corp. engages in growing, harvesting, processing, and selling cannabis products in the British Columbia, Canada. It offers cannabis oil, hemp oil, and other hemp and cannabis derived products, as well as distillate oils. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 2018. Christina Lake Cannabis Corp. was incorporated in 2014 and is headquartered in Vancouver, Canada.
How the Company Makes MoneyCLC generates revenue primarily through the sale of its cannabis products to provincial distributors and retailers across Canada. The company's key revenue streams include direct sales of dried flower, oils, and pre-rolls, as well as potential wholesale opportunities. By establishing partnerships with various provincial governments and retail outlets, CLC ensures a steady distribution channel for its products. Additionally, the company may engage in collaborations with other cannabis brands or businesses, further enhancing its market presence and profitability.

Christina Lake Cannabis Financial Statement Overview

Summary
Christina Lake Cannabis shows mixed financial performance. Revenue growth is positive, but profitability margins are under pressure. The balance sheet is stable, but cash flow management needs improvement.
Income Statement
45
Neutral
Christina Lake Cannabis shows a mixed performance in its income statement. The company has achieved a positive revenue growth rate of 6.89% in the TTM, indicating a growth trajectory. However, the gross profit margin has decreased significantly from 68.41% in 2024 to 34.22% in the TTM, reflecting increased cost pressures. The net profit margin remains low at 6.36%, suggesting limited profitability. The EBIT margin is negative, indicating operational challenges, although the EBITDA margin is positive, showing some operational efficiency.
Balance Sheet
50
Neutral
The balance sheet of Christina Lake Cannabis reveals a moderate financial position. The debt-to-equity ratio is stable at 0.95, indicating a balanced leverage. The return on equity has improved to 10.65% in the TTM, showing better utilization of equity. However, the equity ratio is not explicitly provided, but the total assets and equity suggest a moderate equity base. The company should focus on maintaining its leverage and improving equity returns.
Cash Flow
55
Neutral
The cash flow statement indicates a positive trend with a 12.92% growth in free cash flow in the TTM. The operating cash flow to net income ratio is low, suggesting that cash generation from operations is not fully aligned with net income. The free cash flow to net income ratio is negative, indicating potential cash flow challenges despite improvements. The company needs to enhance its cash flow management to support growth.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue16.15M13.61M11.78M10.07M3.63M0.00
Gross Profit9.13M9.31M3.61M2.98M56.72K4.77M
EBITDA2.09M3.25M-2.62M-938.92K-5.97M-2.14M
Net Income47.72K865.00K-4.13M-1.74M-6.78M-5.32M
Balance Sheet
Total Assets22.08M23.37M15.96M18.79M18.97M17.80M
Cash, Cash Equivalents and Short-Term Investments3.39M1.85M1.47M1.84M1.08M1.84M
Total Debt8.22M10.27M6.15M6.45M3.81M4.06M
Total Liabilities10.02M12.57M8.50M7.66M9.23M8.35M
Stockholders Equity12.06M10.79M7.46M11.14M9.74M9.46M
Cash Flow
Free Cash Flow6.66M-4.13M781.46K394.55K-5.85M-8.10M
Operating Cash Flow3.96M221.02K1.38M1.18M-4.62M-3.32M
Investing Cash Flow2.68M-4.47M-571.37K-790.41K-1.20M-4.78M
Financing Cash Flow-4.73M4.59M-1.15M369.17K5.06M9.20M

Christina Lake Cannabis Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.04
Price Trends
50DMA
0.04
Positive
100DMA
0.04
Negative
200DMA
0.05
Negative
Market Momentum
MACD
<0.01
Negative
RSI
54.67
Neutral
STOCH
33.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CLC, the sentiment is Positive. The current price of 0.04 is above the 20-day moving average (MA) of 0.04, above the 50-day MA of 0.04, and below the 200-day MA of 0.05, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 54.67 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:CLC.

Christina Lake Cannabis Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
54
Neutral
C$12.73M-3.71-18.39%24.30%-68.60%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
51
Neutral
C$11.18M-0.50-53.71%26.36%-8.21%
47
Neutral
C$10.52M-58.33116.45%-100.00%97.20%
46
Neutral
C$4.19M-0.39-664.21%-80.42%
45
Neutral
C$9.92M-5.26-4.55%16.22%-285.37%
40
Underperform
C$10.56M-2.40-23.76%-28.00%38.46%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CLC
Christina Lake Cannabis
0.04
<0.01
14.29%
TSE:MPH
Medicure
1.22
0.33
37.08%
TSE:RVV
Revive Therapeutics
0.01
0.00
0.00%
TSE:PWR
Captiva Verde Land
0.04
0.02
133.33%
TSE:AVNT
Avant Brands
0.98
0.47
92.16%
TSE:TRIP
Red Light Holland
0.03
-0.02
-44.44%

Christina Lake Cannabis Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
Christina Lake Cannabis Secures Credit Facility and Lease Agreement
Positive
Oct 20, 2025

Christina Lake Cannabis Corp. has secured a $1.5 million revolving line of credit from a company director, Mervin Boychuk, with a two-year term and 15% interest, secured by a second mortgage on its property. Additionally, the company entered an 18-month equipment lease agreement with Boychuk, with an option to purchase the equipment post-lease, highlighting strategic financial maneuvers to bolster its operations.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 12, 2025